83 results
Page 4 of 5
6-K
EX-99.1
zwleni1508b iw4n
24 Mar 20
Therapix Biosciences Ltd. Signs Securities Purchase Agreement
12:00am
F-1/A
i76aif
19 Mar 20
Registration statement (foreign) (amended)
12:21pm
F-1
7r5e7 xq5
31 Jan 20
Registration statement (foreign)
12:00am
6-K
EX-99.1
3gec gy7ki7r
11 Dec 19
Annual and Special General Meeting of Shareholders
4:38pm
424B5
5vc76uv0o74 waq6gp
5 Dec 19
Prospectus supplement for primary offering
5:29pm
6-K
EX-99.2
uqn26w5rrw b5a3230bm
7 Nov 19
Therapix Biosciences and Destiny Biosciences Global Corp. Mutually Decide to Discontinue Negotiations on Planned Merger
5:22pm
6-K
EX-99.3
pc0 uxemaq2r43h
7 Nov 19
Therapix Biosciences and Destiny Biosciences Global Corp. Mutually Decide to Discontinue Negotiations on Planned Merger
5:22pm
6-K
EX-99.1
pfq3o909
31 Jul 19
Therapix Biosciences Announces Canadian Product License Issuance for TheraPEA (CannAmide™), a Non-Opiate Based Pain Management Supplement
4:03pm
6-K
EX-99.1
da8a7zyb7
23 Jul 19
Therapix Biosciences Signs LOI to Merge With Destiny Biosciences Global Corp. in a
4:05pm
6-K
EX-99.1
11ztw3ko hl
5 Jul 19
Therapix Biosciences Announces First Quarter 2019 Condensed Financial Data
6:08am
424B5
k878yzw2jknp0va8l4
1 Apr 19
Prospectus supplement for primary offering
6:57am
6-K
EX-99.1
m4ipc6
17 Jan 19
Annual General Meeting of Shareholders
4:05pm
6-K
EX-99.1
2recrkftptcf65i
6 Dec 18
Therapix Biosciences Reports Third
6:18am
6-K
EX-99.1
y5da9hbofgmuoi
28 Nov 18
Management’s Discussion and Analysis of Financial Condition and Results of Operations
6:27am
6-K
EX-99.1
9i65kez
24 Oct 18
Report of Foreign Private Issuer
6:45am
424B2
yag3 hj56smyl
9 Aug 18
Prospectus for primary offering
11:19am
F-3/A
5zfum
17 Jul 18
Shelf registration (foreign) (amended)
1:29pm
F-3
uafp ttqayu5je0a1u
20 Jun 18
Shelf registration (foreign)
2:38pm